MRNA Stock Analysis: Buy, Sell, or Hold?
MRNA - Moderna, Inc. Common Stock
$45.99
-1.74 (-3.65%)
▼
5d:
-6.26%
30d:
-13.03%
90d:
-17.83%
HOLD
LOW Confidence
Analysis Updated: Jun 10, 2026 12:00 AM ET
Earnings: Jul 31, 2026
Smart Money Accumulation
None View Scanner →
Strength: 7.3/10
Get Alerted When MRNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MRNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MRNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MRNA is currently trading at $45.99, which is considered oversold relative to its 30-day fair value range of $46.18 to $50.70.
Technical Outlook: Technically, MRNA is showing sideways momentum. Immediate support is located at $43.90, while resistance sits at $51.90. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MRNA is showing sideways momentum. Immediate support is located at $43.90, while resistance sits at $51.90. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$46.18 -
$50.70
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
Protect Your Profits
Holding MRNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.6%)
- BEARISH: Trading above Wall St target ($43.30)
- CAUTION: Recommendation downgraded due to -6.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$46.18 -
$50.70
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$43.90
Resistance Level
$51.90
Current Trend
Sideways
Technical data as of
Jun 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.73
Wall Street Target
$43.30
(-5.8%)
Revenue Growth (YoY)
260.2%
Earnings Growth (YoY)
-85.1%
Profit Margin
-143.6%
Share & Embed Analysis
Last updated: June 11, 2026 6:02 AM ET
Data refreshes hourly during market hours. Next update: 7:02 AM
Data refreshes hourly during market hours. Next update: 7:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRNA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Stephen Hoge
SELL
160009 shares
2026-02-23
Ro Khanna
BUY
2026-01-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 59 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 60 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 53 HOLD |
Advanced MRNA Option Strategies
Professional options setups generated by AI based on today's MRNA price and gamma walls.
